🔎 Trials Near Me

Dachaigh › Scleroderma › New York › New York City

Sgrùdaidhean clionaigeach Scleroderma ann an New York City, NY

Tha aon sgrùdadh airson Scleroderma a’ lorg phàirtichean aig làrach ann no faisg air New York City. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

A’ fastadhÌre 1
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • NYP/Weill Cornell Medical Center, New York
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT03816345

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

A’ fastadhÌre 3
  • Hospital for Special Surgery, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University Medical Center-New York Presbyterian Hospital, New York
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07497087

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

A’ fastadhÌre 1
  • Icahn School of Medicine at Mount Sinai, New York
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT07085104

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

A’ fastadhÌre 2/3
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05878717

Platform Clinical Study for Conquering Scleroderma

A’ fastadhÌre 2
  • Hospital for Special Surgery, New York
  • Columbia University Medical Center, New York
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

A’ fastadhÌre 2/3
  • Columbia University Irving Medical Center, New York
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06328777

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

A’ fastadhÌre 1/2
  • Nkarta Investigational Site, New York
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT06733935

A Study of AZD0120 in Autoimmune Diseases

A’ fastadhÌre 1
  • Research Site, New York
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT07295847

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

A’ fastadhÌre 1
  • Montefiore Medical Center, New York
Aoisean 12 gu 70 · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT06308978

Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

A’ fastadhÌre 2
  • Hospital for Special Surgery, New York
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 27 Màrt 2026 · NCT03844061

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

A’ fastadhÌre 2
  • aTyr Investigative Site, New York
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Cèit 2025 · NCT05892614

Sgrùdaidhean Scleroderma ann am bailtean eile

Sgrùdaidhean eile ann an New York City

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.